FdaApplication

BLA 125446

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTakeda Pharmaceuticals U.S.A., Inc.
application_typeBLA
approval_date2013-06-26

Products (5)

ProductActive ingredientStrengthDosage form
RIXUBIS—500IUFor Injection
RIXUBIS—250IUFor Injection
RIXUBIS—3000IUFor Injection
RIXUBIS—1000IUFor Injection
RIXUBIS—2000IUFor Injection

5 products